Testing the Lumito scanner with the final product design
Lumito's research and development team has attended the operational testing of the company's scanner with the final product design at the Swedish partner, Optronics Partner pr. Since a few months ago Lumito is in the commercialization phase with production as an area of focus.
The purpose of the briefing was to test all the scanner's functions and that these communicate with each other and to ensure that the requirements are met.
- Our meeting was positive, and we are in an intensive verification phase to ensure that the scanner meets all the requirements. Further testing at system level will take place internally, at Lumito and at Optronics Partner, as well as externally, comments Andreas Johansson, Lumito's Technical Manager.
Caption above: Lumito's scanner has been assembled and tested by the Swedish production partner Optronic Partner pr under the supervision of Lumito's R&D team. From left: Krzysztof Krawczyk, Project Manager Lumito, Markus Bylesjö, Development Manager Optronic, Andreas Johansson, Technical Manager Lumito, Charles Lundberg, Optronic Project Manager, Magnus Helgstrand, Senior Software Engineer
For further information, please contact:
Lumito's CEO, Mattias Lundin
e-mail: ml@lumito.se
Ph: +46 76 868 45 09
www.lumito.se/en
Lumito specializes in medical technology for digital pathology. Through its proprietary and patented technology, Lumito aims to provide healthcare providers with a powerful tool to meet the demands for fast and safe tissue diagnostics in personalized healthcare. The technology enables higher contrast images without irrelevant background information, making it easier for pathologists to find cancer indications. The technology, based on Up Converting NanoParticles (UCNP), has the potential to significantly improve the diagnosis of tissue samples through higher quality analyses and shortened analysis times. The method has several potential applications, of which digital pathology remains the focus of Lumito and the initial launch in researchers use only. The company is a spin-off from a research group at the Department of Atomic Physics and Laser Centre. www.lumito.se/en.
The share is traded on NGM Nordic SME, under the name LUMITO and Mentor is Mangold Fondkommission, phone: 08-503 015 50.
Tags:
